Global Covid Testing Kit Market Growth (Status and Outlook) 2023-2029

Global Covid Testing Kit Market Growth (Status and Outlook) 2023-2029

COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Tests for viral presence are used to diagnose illness and to allow public health authorities to identify and contain outbreaks as quickly as possible. Antibody tests instead support attempts to estimate the prevalence of disease within a population. Another, speculative use is to identify individuals who the antibodies have rendered immune to the disease, although research has yet to confirm that a positive test confers such immunity.
Individual jurisdictions have adopted a broad range of testing protocols. They vary in choosing whom to test, how often to test, analysis protocols, sample collection and the uses of test results. This variation has likely significantly impacted countries' reported statistics, including case fatality rates and the age distribution of cases, due to sampling bias.
Testing is often performed in automated, high-throughput centralized medical laboratories by medical laboratory scientists. Alternatively, point-of-care testing can be done in physician's offices, workplaces or transit hubs.
LPI (LP Information)' newest research report, the “Covid Testing Kit Industry Forecast” looks at past sales and reviews total world Covid Testing Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected Covid Testing Kit sales for 2023 through 2029. With Covid Testing Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Covid Testing Kit industry.
This Insight Report provides a comprehensive analysis of the global Covid Testing Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Covid Testing Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Covid Testing Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Covid Testing Kit and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Covid Testing Kit.
The global Covid Testing Kit market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
According to our prediction, Asia Pacific is the largest consumer of Covid Testing Kit in global market, with an estimated consumption market share of 69.22% on June.The second place is Europe, following Asia Pacific with the consumption market share of 15.88% on June.
The classification of Covid Testing Kit includes Nucleic Acid Testing and Antibody Testing. The share of Nucleic Acid Testing in the market is 93.05% on June.
The application of Covid Testing Kit includes hospitals and scientific research. In addition, the market share of scientific research is 61.84% on June.
This report presents a comprehensive overview, market shares, and growth opportunities of Covid Testing Kit market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nucleic Acid Testing
Antibody Testing
Segmentation by application
Hospitals
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cellex
Abbott
Roche
BioMedomics
BD
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE

Please note: The report will take approximately 2 business days to prepare and deliver.